Caleb Houstan
26-27 Projection
FT%: league rank #1, top 5 in the league.
TO: league rank #8, top 10 in the league.
ORL
Changed teams this offseason (ATL to ORL). Has been available for roughly 51% of games across recent seasons, which pulls the games projection down.
Value
+-3.76
League Leader0.2
This Player0.2
League Average1.3
Lower is better for this stat.
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 22-23 | #398 |
| 23-24 | #374 |
| 24-25 | #382 |
| 25-26 | n/a |
| 26-27 Projection | #418 |
Stat Trend
Track role, durability, and category growth by season.
Full data
| Season | PTS |
|---|---|
| 22-23 | 3.8 |
| 23-24 | 4.3 |
| 24-25 | 4.1 |
| 25-26 | 2.3 |
| 26-27 Projection | 4.4 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 0 |
| Nov 2025 | 3.4 |
| Dec 2025 | 3 |
| Jan 2026 | 1.5 |
| Mar 2026 | 1.3 |
| Apr 2026 | 5.5 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Season History
Compare season stats and fantasy ranks for draft analysis.
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 24 | ORL | 52 | 0 | 10.7 | #418 | -3.76 | 4.4 | 1.3 | 0.5 | 0.3 | 0.1 | 1.1 | 43.5% | 3.1 | 98.0% | 0.4 | 0.3 |
| 25-26 | 23 | ATL | 18 | 0 | 4.2 | n/a | n/a | 2.3 | 0.6 | 0.2 | 0.1 | 0.1 | 0.6 | 53.8% | 1.4 | 100.0% | 0.2 | 0.2 |
| 24-25 | 22 | ORL | 58 | 0 | 13.6 | #382 | -4.27 | 4.1 | 1.3 | 0.6 | 0.4 | 0.1 | 1.1 | 42.1% | 3.3 | 88.2% | 0.3 | 0.2 |
| 23-24 | 21 | ORL | 59 | 0 | 13.8 | #374 | -4.51 | 4.3 | 1.4 | 0.5 | 0.3 | 0.1 | 1.2 | 38.8% | 3.5 | 80.8% | 0.4 | 0.3 |
| 22-23 | 20 | ORL | 51 | 0 | 15.9 | #398 | -5.09 | 3.8 | 1.9 | 0.6 | 0.2 | 0.1 | 0.9 | 36.3% | 3.6 | 83.3% | 0.4 | 0.4 |